Competing Risks, Treatment Switching, and Informative Censoring.
Publication
, Journal Article
Thomas, LE; Turakhia, MP; Pencina, MJ
Published in: JAMA Cardiol
August 1, 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
August 1, 2021
Volume
6
Issue
8
Start / End Page
871 / 873
Location
United States
Related Subject Headings
- Treatment Switching
- Risk Assessment
- Models, Statistical
- Humans
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Thomas, L. E., Turakhia, M. P., & Pencina, M. J. (2021). Competing Risks, Treatment Switching, and Informative Censoring. JAMA Cardiol, 6(8), 871–873. https://doi.org/10.1001/jamacardio.2021.1239
Thomas, Laine Elliott, Mintu P. Turakhia, and Michael J. Pencina. “Competing Risks, Treatment Switching, and Informative Censoring.” JAMA Cardiol 6, no. 8 (August 1, 2021): 871–73. https://doi.org/10.1001/jamacardio.2021.1239.
Thomas LE, Turakhia MP, Pencina MJ. Competing Risks, Treatment Switching, and Informative Censoring. JAMA Cardiol. 2021 Aug 1;6(8):871–3.
Thomas, Laine Elliott, et al. “Competing Risks, Treatment Switching, and Informative Censoring.” JAMA Cardiol, vol. 6, no. 8, Aug. 2021, pp. 871–73. Pubmed, doi:10.1001/jamacardio.2021.1239.
Thomas LE, Turakhia MP, Pencina MJ. Competing Risks, Treatment Switching, and Informative Censoring. JAMA Cardiol. 2021 Aug 1;6(8):871–873.
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
August 1, 2021
Volume
6
Issue
8
Start / End Page
871 / 873
Location
United States
Related Subject Headings
- Treatment Switching
- Risk Assessment
- Models, Statistical
- Humans
- 3201 Cardiovascular medicine and haematology